100 related articles for article (PubMed ID: 23397397)
21. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.
Ma CS; Nichols KE; Tangye SG
Annu Rev Immunol; 2007; 25():337-79. PubMed ID: 17201683
[TBL] [Abstract][Full Text] [Related]
22. Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia.
Recher M; Fried AJ; Massaad MJ; Kim HY; Rizzini M; Frugoni F; Walter JE; Mathew D; Eibel H; Hess C; Giliani S; Umetsu DT; Notarangelo LD; Geha RS
Clin Immunol; 2013 Feb; 146(2):84-9. PubMed ID: 23280491
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis.
Kanegane H; Yang X; Zhao M; Yamato K; Inoue M; Hamamoto K; Kobayashi C; Hosono A; Ito Y; Nakazawa Y; Terui K; Kogawa K; Ishii E; Sumazaki R; Miyawaki T
Pediatr Allergy Immunol; 2012 Aug; 23(5):488-93. PubMed ID: 22433061
[TBL] [Abstract][Full Text] [Related]
24. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
Engel P; Eck MJ; Terhorst C
Nat Rev Immunol; 2003 Oct; 3(10):813-21. PubMed ID: 14523387
[TBL] [Abstract][Full Text] [Related]
25. The X-linked lymphoproliferative syndrome gene product SAP regulates B cell function through the FcgammaRIIB receptor.
Li C; Chung B; Tao J; Iosef C; Aoukaty A; Wang Y; Tan R; Li SS
Cell Signal; 2008 Nov; 20(11):1960-7. PubMed ID: 18662772
[TBL] [Abstract][Full Text] [Related]
26. Disease-causing SAP mutants are defective in ligand binding and protein folding.
Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
[TBL] [Abstract][Full Text] [Related]
27. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.
Nichols KE; Ma CS; Cannons JL; Schwartzberg PL; Tangye SG
Immunol Rev; 2005 Feb; 203():180-99. PubMed ID: 15661030
[TBL] [Abstract][Full Text] [Related]
28. Clinical Flow Cytometric Screening of SAP and XIAP Expression Accurately Identifies Patients with SH2D1A and XIAP/BIRC4 Mutations.
Gifford CE; Weingartner E; Villanueva J; Johnson J; Zhang K; Filipovich AH; Bleesing JJ; Marsh RA
Cytometry B Clin Cytom; 2014 Feb; ():. PubMed ID: 26305518
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
[TBL] [Abstract][Full Text] [Related]
30. SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation.
Nagy N; Maeda A; Bandobashi K; Kis LL; Nishikawa J; Trivedi P; Faggioni A; Klein G; Klein E
Int J Cancer; 2002 Aug; 100(4):433-40. PubMed ID: 12115526
[TBL] [Abstract][Full Text] [Related]
31. The role of SAP and SLAM family molecules in the humoral immune response.
Ma CS; Deenick EK
Ann N Y Acad Sci; 2011 Jan; 1217():32-44. PubMed ID: 21091715
[TBL] [Abstract][Full Text] [Related]
32. SAP couples Fyn to SLAM immune receptors.
Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
[TBL] [Abstract][Full Text] [Related]
33. Immune regulation by SLAM family receptors and SAP-related adaptors.
Veillette A
Nat Rev Immunol; 2006 Jan; 6(1):56-66. PubMed ID: 16493427
[TBL] [Abstract][Full Text] [Related]
34. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
[TBL] [Abstract][Full Text] [Related]
36. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
Furukawa H; Tohma S; Kitazawa H; Komori H; Nose M; Ono M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):37-44. PubMed ID: 20049647
[TBL] [Abstract][Full Text] [Related]
37. SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9.
Simarro M; Lanyi A; Howie D; Poy F; Bruggeman J; Choi M; Sumegi J; Eck MJ; Terhorst C
Int Immunol; 2004 May; 16(5):727-36. PubMed ID: 15096483
[TBL] [Abstract][Full Text] [Related]
38. SAP binds to CD22 and regulates B cell inhibitory signaling and calcium flux.
Ostrakhovitch EA; Wang Y; Li SS
Cell Signal; 2009 Apr; 21(4):540-50. PubMed ID: 19150402
[TBL] [Abstract][Full Text] [Related]
39. Structural characterization of disease-causing mutations on SAP and the functional impact on the SLAM peptide: a molecular dynamics approach.
Chandrasekaran P; Rajasekaran R
Mol Biosyst; 2014 Jul; 10(7):1869-80. PubMed ID: 24770789
[TBL] [Abstract][Full Text] [Related]
40. Fine-tuning of immune responses by SLAM-related receptors.
Bhat R; Eissmann P; Endt J; Hoffmann S; Watzl C
J Leukoc Biol; 2006 Mar; 79(3):417-24. PubMed ID: 16365151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
